Universal Biosensors, Inc.: depreciation, depletion and amortization

What this measure means

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Exact concept: us-gaap:DepreciationDepletionAndAmortization. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2018-01-01 to 2024-12-31. The SEC response was captured on 2026-09-21.

Selected filing history

Related financial histories

• Universal Biosensors, Inc.: total assets
• Universal Biosensors, Inc.: total liabilities
• Universal Biosensors, Inc.: stockholders equity
• Universal Biosensors, Inc.: cash and cash equivalents
• Universal Biosensors, Inc.: net income or loss
• Universal Biosensors, Inc.: operating cash flow
• Universal Biosensors, Inc.: capital expenditure payments
• Universal Biosensors, Inc.: revenue
• Universal Biosensors, Inc.: financing cash flow
• Universal Biosensors, Inc.: investing cash flow
• Universal Biosensors, Inc.: retained earnings or deficit
• Universal Biosensors, Inc.: basic weighted-average shares
• Universal Biosensors, Inc.: diluted weighted-average shares
• Universal Biosensors, Inc.: basic earnings per share
• Universal Biosensors, Inc.: diluted earnings per share
• Universal Biosensors, Inc.: income tax expense or benefit
• Universal Biosensors, Inc.: net property, plant and equipment
• Universal Biosensors, Inc.: share-based compensation expense
• Universal Biosensors, Inc.: operating income or loss
• Universal Biosensors, Inc.: current assets
• Universal Biosensors, Inc.: interest expense
• Universal Biosensors, Inc.: current liabilities
• Universal Biosensors, Inc.: current accounts payable
• Universal Biosensors, Inc.: net finite-lived intangible assets
• Universal Biosensors, Inc.: net current accounts receivable
• Universal Biosensors, Inc.: net inventory
• Universal Biosensors, Inc.: gross profit
• Universal Biosensors, Inc.: selling, general and administrative expense
• Universal Biosensors, Inc.: research and development expense
• Universal Biosensors, Inc.: common shares outstanding
• Universal Biosensors, Inc.: cash including restricted cash
• Universal Biosensors, Inc.: accumulated other comprehensive income or loss
• Universal Biosensors, Inc.: operating lease right-of-use asset
• Universal Biosensors, Inc.: operating lease liability
• Universal Biosensors, Inc.: long-term debt
• Universal Biosensors, Inc.: gross property, plant and equipment
• Universal Biosensors, Inc.: accumulated depreciation on property, plant and equipment
• Universal Biosensors, Inc.: other noncurrent assets
• Universal Biosensors, Inc.: other noncurrent liabilities
• Universal Biosensors, Inc.: accrued current liabilities
• Universal Biosensors, Inc.: current contract liabilities
• Universal Biosensors, Inc.: net deferred tax assets
• Universal Biosensors, Inc.: net deferred tax liabilities
• Universal Biosensors, Inc.: pre-tax income or loss from continuing operations
• Universal Biosensors, Inc.: profit or loss including noncontrolling interests
• Universal Biosensors, Inc.: comprehensive income or loss
• Universal Biosensors, Inc.: general and administrative expense
• Universal Biosensors, Inc.: depreciation expense
• Universal Biosensors, Inc.: other nonoperating income or expense
• Universal Biosensors, Inc.: nonoperating income or expense
• Universal Biosensors, Inc.: operating lease payments
• Universal Biosensors, Inc.: change in accounts receivable
• Universal Biosensors, Inc.: change in inventories

Inspect the source

Entity

Universal Biosensors, Inc. / CIK 0001279695

Captured

2026-09-21T17:18:14.585Z

SEC response SHA-256

568b84ed8e1ce5f21bc744f4571abfcf3b9e9a7c823cda23853eefe0a23f3f1d

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001279695.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))